Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September.

Court halts sale of first FDA-approved biosimilar

The sale of Sandoz's biosimilar version of Amgen Inc,'s drug Neupogen is on hold.

Hold your biosimilar horses.

A judge has temporarly blocked the sale of Sandoz's biosimilar version of Amgen Inc,'s drug Neupogen.

Approved by the FDA in March, and the drug is the first biosimilar to be sold in the U.S., but a U.S. Court of Appeals for the Federal Circuit issued an injunction preventing the sale until the court resolves a pending appeal over the medication's release, reported The Recorder.

"In seeking the injunction from the Federal Circuit, lawyers for Amgen argued that the case presents issues of first impression under the 2010 Biologics Price Competition and Innovation Act, which created a new pathway for the approval of biosimilar products," wrote The Recorder. "Argument is set for June 3."

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO